About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials in Chicago | 195 Studies

Clinical Trials SchizophreniaChicago

Schizophrenia Clinical Trials in Chicago

Find 195 clinical trials for schizophrenia near Chicago, Illinois. Connect with research centers in your area.

All Schizophrenia trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 101-120 of 195 trials

CompletedA Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective DisorderThis Phase IV, randomized, parallel-group study is designed to evaluate the cataractogenic potential of quetiapine fumarate (SEROQUEL) compared with that of a putative…NCT00206102·Little Rock, Arkansas and 62 others

Schizophrenia Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

RecruitingCognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1In Study 1, investigators will test the ability of each of the seven paradigms to differentiate between schizophrenia (SZ)/schizoaffective disorder (SZA) and matched healthy…NCT07853807·Irvine, California and 4 others

CompletedPharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareUnderstudied drugs will be administered to children per standard of care as prescribed by their treating caregiver and only biological sample collection during the time of drug…NCT01431326·Anchorage, Alaska and 51 others

CompletedOpen-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.The purpose of this open-label study is to evaluate the long-term (6-month) safety and tolerability of extended-release paliperidone, an atypical antipsychotic, given in flexible…NCT00488319·Cerritos, California and 52 others

CompletedIntramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With SchizophreniaTo evaluate the overall effectiveness of aripiprazole intramuscular (IM) depot as maintenance treatment in patients with schizophrenia.NCT00731549·Chandler, Arizona and 213 others

CompletedAripiprazole in Adolescents With SchizophreniaThe purpose of this trial is to test the safety and efficacy of aripiprazole in adolescent patients with schizophrenia for a period of at least 6 weeks.NCT00102063·Birmingham, Alabama and 54 others

CompletedCAFE Comparison of Atypicals in First Episode of PsychosisThe purpose of this study is to compare the effectiveness, tolerability, and efficacy of the currently available atypical antipsychotic drugs olanzapine (2.5-20 mg/day)…NCT00034892·Stanford, California and 25 others

TerminatedStudy to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With SchizophreniaStudy to evaluate the safety and efficacy of luvadaxistat compared with placebo on improving cognitive performance in participants with schizophrenia.NCT05182476·Phoenix, Arizona and 48 others

RecruitingA Long-Term Open-Label Study of ML-007C-MA in Adults With SchizophreniaML-007C-MA-212 is a 52-week open-label study designed to evaluate the long-term safety, tolerability, and effectiveness of ML-007C-MA in participants with schizophrenia who have…NCT07459647·Little Rock, Arkansas and 44 others

CompletedA Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25306)This randomized, multi-center, double-blind, parallel-group, placebo-controlled study will evaluate the efficacy and safety of RO4917838 (bitopertin) in patients with…NCT01235585·Carson, California and 119 others

CompletedRandomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute SchizophreniaThis is a Phase 2, randomized, double-blind, placebo-controlled, multi-center inpatient study to evaluate the efficacy and safety of LB-102 in adult patients diagnosed with…NCT06179108·Bentonville, Arkansas and 24 others

CompletedA Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With SchizophreniaThe primary objective of this study is to evaluate the long term safety and tolerability of ALKS 3831 in subjects with schizophrenia.NCT02669758·Little Rock, Arkansas and 30 others

CompletedA Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With SchizophreniaA clinical trial to study the efficacy and safety of an investigational drug in acutely psychotic people with schizophrenia.NCT04092686·Rogers, Arkansas and 52 others

CompletedFlexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With SchizophreniaTo evaluate the safety and tolerability of the long-term treatment with Lu AF35700.NCT02892422·Bellflower, California and 101 others

Terminated20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative SymptomsThe purpose of this study is to evaluate the effect of AMG 747 on negative symptoms of schizophrenia in patients who are stable on current antipsychotic treatment.NCT01568216·Anaheim, California and 37 others

CompletedLong-Acting Injectable Risperidone in the Treatment of SchizophreniaIn the proposed study 450 veterans with a primary diagnosis of schizophrenia who had at least one psychiatric hospitalization for schizophrenia in the previous 2 years would be…NCT00132314·Tuscaloosa, Alabama and 18 others

CompletedEfficacy and Safety of Elpipodect (MK-8189) in Participants With an Acute Episode of Schizophrenia (MK-8189-008)The purpose of this study was to evaluate the efficacy and safety of elpipodect at a range of doses (8 mg, 16 mg, and 24 mg once daily \[QD\]) in adult participants who have an…NCT04624243·Bentonville, Arkansas and 120 others

CompletedDexmedetomidine in the Treatment of Agitation Associated With SchizophreniaThis is a definitive study to support the safety and efficacy evaluation of BXCL501 for the acute treatment of agitation in schizophrenia.NCT04268303·Little Rock, Arkansas and 14 others

CompletedA Study of the Efficacy (Effectiveness) of Paliperidone Palmitate in the Prevention of Recurrence of the Symptoms of Schizophrenia.The purpose of this study is to evaluate the efficacy of paliperidone palmitate compared with placebo in the prevention of recurrence of the symptoms of schizophrenia and to…NCT00111189·Little Rock, Arkansas and 54 others

TerminatedEffects of GLYX-13 on Learning and Memory in Healthy Individuals and Those With Psychiatric IllnessThe present study proposes to evaluate the potential cognitive enhancing effects of GLYX-13, an NMDAR partial agonist, among a group of healthy adults and those with psychiatric…NCT01844726·Chicago, Illinois

PreviousPage 6 of 10Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia